Inactivated human platelet lysate with psoralen: a new perspective for mesenchymal stromal cell production in Good Manufacturing Practice conditions

BACKGROUND AIMS: Mesenchymal stromal cells (MSC) are ideal candidates for regenerative and immunomodulatory therapies. The use of xenogeneic protein–free Good Manufacturing Practice–compliant growth media is a prerequisite for clinical MSC isolation and expansion. Human platelet lysate (HPL) has bee...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cytotherapy
Autors principals: Castiglia, Sara, Mareschi, Katia, Labanca, Luciana, Lucania, Graziella, Leone, Marco, Sanavio, Fiorella, Castello, Laura, Rustichelli, Deborah, Signorino, Elena, Gunetti, Monica, Bergallo, Massimiliano, Bordiga, Anna Maria, Ferrero, Ivana, Fagioli, Franca
Format: Artigo
Idioma:Inglês
Publicat: International Society for Cellular Therapy. Published by Elsevier Inc. 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7185570/
https://ncbi.nlm.nih.gov/pubmed/24529555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcyt.2013.12.008
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars